A slowdown in production of a heart device made in Minnesota by Boston Scientific may have negative implications for the Twin Cities. The device is manufactured at the company's facility in Maple Grove. Company officials have not disclosed details of their restructuring plan, which could impact operations at the Maple Grove site.

For more information on the potential effects of the slowdown, readers can refer to the Star Tribune, which has reported on the situation. Further details on the restructuring plan and its implications are not available at this time.